Back to top
more

Anthem, Inc. (ANTM)

(Delayed Data from NYSE)

$261.70 USD

261.70
1,184,666

+0.11 (0.04%)

Updated May 3, 2019 04:00 PM ET

After-Market: $261.69 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.

Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Sportsman's Warehouse, DXP Enterprises, Anthem and Centene Corp highlighted as Zacks Bull and Bear of the Day

Centene vs. Anthem: Which is a Better-Positioned Stock?

by Zacks Equity Research

Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.

UnitedHealth to Aid Eligible Medicaid Members in Indiana

by Zacks Equity Research

UnitedHealth Group (UNH) intends to improve health outcomes of Medicaid members in Indiana, where it already has a strong presence.

Why Is Anthem (ANTM) Down 0.9% Since Last Earnings Report?

by Zacks Equity Research

Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sheraz Mian headshot

Top Research Reports for Microsoft, Oracle & Medtronic

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Microsoft (MSFT), Oracle (ORCL) and Medtronic (MDT).

Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM

by Zacks Equity Research

Zacks Industry Outlook Highlights: SEM, MOH, JYNT and HUM

Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?

by Zacks Equity Research

Banking on an upbeat outlook and rising membership, Anthem (ANTM) holds immense potential to reap benefits for investors.

Here's Why Investors Should Bet on Select Medical Stock Now

by Zacks Equity Research

Select Medical (SEM) remains well-poised for growth on the back of improving revenues, strategic buyouts and impressive capital position.

Srijita Guha headshot

3 Health Insurers That Surpass the S&P 500 Year to Date

by Srijita Guha

We zero in on three health insurers that have managed to outperform the broader index year to date, banking on core strength.

Sheraz Mian headshot

Top Stock Reports for Visa, GlaxoSmithKline & Anthem

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Visa (V), salesforce.com (CRM) and Anthem (ANTM).

Anthem, Quest Tie up to Improve Healthcare Across the US

by Zacks Equity Research

Anthem (ANTM) teams up with Quest in order to improve health outcomes to consumers with the help of their innovative solutions.

Here's Why You Should Add Humana (HUM) to Your Portfolio

by Zacks Equity Research

Riding high on its Medicare line of business and strategic initiatives, Humana (HUM) holds enough potential to reap benefits for investors.

Acadia Healthcare (ACHC) Q2 Earnings Top Estimates, Fall Y/Y

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q2 earnings are hurt year over year by lower patient days and revenue per patient day, partly offset by decreased expenses.

Sejuti Banerjea headshot

6 Stocks Worth Buying Post Earnings

by Sejuti Banerjea

Nobody really knows how the pandemic will play out in the second half of the year, but here are a few stocks that look headed in the right direction.

Cigna (CI) Earnings Surpass Estimates in Q2, Improve Y/Y

by Zacks Equity Research

Cigna's (CI) Q2 earnings gain from a strong fundamental performance and reduced medical costs from delayed treatments amid the COVID-19 pandemic.

Company News for Jul 30, 2020

by Zacks Equity Research

Companies in the news are: ADP, ANTM, SHOP, ETN

Top Ranked Growth Stocks to Buy for July 30th

by Zacks Equity Research

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 30th.

Anthem (ANTM) Q2 Earnings Surpass Estimates, Improve Y/Y

by Zacks Equity Research

Anthem's (ANTM) Q2 results reflect higher premium revenues and a solid contribution from Government business.

Mark Vickery headshot

Big Tech Goes to Capitol Hill; Plus Q2 from BA, GE, SPOT & More

by Mark Vickery

What we may be seeing today is a preview of concerns of progressive lawmakers regarding anti-trust measures.

Earnings Data Deluge

by Zacks Equity Research

Earnings Data Deluge

Anthem (ANTM) Q2 Earnings Beat Estimates

by Zacks Equity Research

Anthem (ANTM) delivered earnings and revenue surprises of 4.90% and -0.87%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Top Ranked Growth Stocks to Buy for July 29th

by Zacks Equity Research

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 29th

5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus

by Zacks Equity Research

Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.

Is a Surprise Coming for Anthem (ANTM) This Earnings Season?

by Zacks Equity Research

Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Teladoc (TDOC) Q2 Earnings to Gain From Coronavirus-Led Demand

by Zacks Equity Research

Teladoc Health (TDOC) Q2 earnings are likely to have gained from higher virtual health visits and membership growth from coronavirus-led demand.